annual CFF:
-$983.00M-$272.00M(-38.26%)Summary
- As of today (June 22, 2025), EW annual cash flow from financing activities is -$983.00 million, with the most recent change of -$272.00 million (-38.26%) on December 31, 2024.
- During the last 3 years, EW annual CFF has fallen by -$626.70 million (-175.89%).
- EW annual CFF is now -2916.62% below its all-time high of $34.90 million, reached on December 31, 2013.
Performance
EW Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$258.00M-$286.60M(-1002.10%)Summary
- As of today (June 22, 2025), EW quarterly cash flow from financing activities is -$258.00 million, with the most recent change of -$286.60 million (-1002.10%) on March 1, 2025.
- Over the past year, EW quarterly CFF has dropped by -$319.70 million (-518.15%).
- EW quarterly CFF is now -303.47% below its all-time high of $126.80 million, reached on June 30, 2017.
Performance
EW quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$1.30B-$319.70M(-32.52%)Summary
- As of today (June 22, 2025), EW TTM cash flow from financing activities is -$1.30 billion, with the most recent change of -$319.70 million (-32.52%) on March 1, 2025.
- Over the past year, EW TTM CFF has dropped by -$860.00 million (-194.26%).
- EW TTM CFF is now -3832.66% below its all-time high of $34.90 million, reached on December 31, 2013.
Performance
EW TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
EW Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -38.3% | -518.1% | -194.3% |
| 3 y3 years | -175.9% | +29.9% | -189.4% |
| 5 y5 years | -750.4% | +56.0% | -74.5% |
EW Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -175.9% | +38.0% | -518.1% | +73.6% | -194.3% | +17.8% |
| 5 y | 5-year | -750.4% | +38.0% | -518.1% | +73.6% | -645.3% | +17.8% |
| alltime | all time | -2916.6% | +38.0% | -303.5% | +73.6% | -3832.7% | +17.8% |
EW Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$258.00M(-1002.1%) | -$1.30B(+32.5%) |
| Dec 2024 | -$983.00M(+38.3%) | $28.60M(-102.9%) | -$983.00M(-31.0%) |
| Sep 2024 | - | -$976.70M(+911.1%) | -$1.42B(+140.9%) |
| Jun 2024 | - | -$96.60M(-256.6%) | -$591.40M(+33.6%) |
| Mar 2024 | - | $61.70M(-114.9%) | -$442.70M(-37.7%) |
| Dec 2023 | -$711.00M(-55.1%) | -$413.20M(+188.3%) | -$711.00M(-37.4%) |
| Sep 2023 | - | -$143.30M(-375.0%) | -$1.14B(+6.9%) |
| Jun 2023 | - | $52.10M(-125.2%) | -$1.06B(-25.3%) |
| Mar 2023 | - | -$206.60M(-75.4%) | -$1.42B(-10.2%) |
| Dec 2022 | -$1.58B(+344.7%) | -$838.40M(+1099.4%) | -$1.58B(+96.1%) |
| Sep 2022 | - | -$69.90M(-77.3%) | -$808.10M(+15.6%) |
| Jun 2022 | - | -$308.10M(-16.3%) | -$699.20M(+55.3%) |
| Mar 2022 | - | -$368.10M(+493.7%) | -$450.10M(+26.3%) |
| Dec 2021 | -$356.30M(-26.8%) | -$62.00M(-259.0%) | -$356.30M(+40.9%) |
| Sep 2021 | - | $39.00M(-166.1%) | -$252.90M(-1.9%) |
| Jun 2021 | - | -$59.00M(-78.5%) | -$257.90M(+47.5%) |
| Mar 2021 | - | -$274.30M(-762.6%) | -$174.80M(-64.1%) |
| Dec 2020 | -$486.90M(+321.2%) | $41.40M(+21.8%) | -$486.90M(-0.9%) |
| Sep 2020 | - | $34.00M(+41.1%) | -$491.30M(+0.1%) |
| Jun 2020 | - | $24.10M(-104.1%) | -$490.90M(-34.2%) |
| Mar 2020 | - | -$586.40M(-1684.9%) | -$746.40M(+545.7%) |
| Dec 2019 | -$115.60M(-89.5%) | $37.00M(+7.6%) | -$115.60M(-88.4%) |
| Sep 2019 | - | $34.40M(-114.9%) | -$997.30M(-8.4%) |
| Jun 2019 | - | -$231.40M(-621.2%) | -$1.09B(-0.8%) |
| Mar 2019 | - | $44.40M(-105.3%) | -$1.10B(-0.3%) |
| Dec 2018 | -$1.10B(+132.7%) | -$844.70M(+1389.8%) | -$1.10B(+126.8%) |
| Sep 2018 | - | -$56.70M(-76.4%) | -$485.50M(+18.8%) |
| Jun 2018 | - | -$240.70M(-688.5%) | -$408.50M(+896.3%) |
| Mar 2018 | - | $40.90M(-117.9%) | -$41.00M(-91.3%) |
| Dec 2017 | -$473.20M(+76.2%) | -$229.00M(-1228.1%) | -$473.20M(+97.9%) |
| Sep 2017 | - | $20.30M(-84.0%) | -$239.10M(+22.2%) |
| Jun 2017 | - | $126.80M(-132.4%) | -$195.60M(-32.7%) |
| Mar 2017 | - | -$391.30M(-7772.5%) | -$290.70M(+8.3%) |
| Dec 2016 | -$268.50M(+69.3%) | $5.10M(-92.0%) | -$268.50M(-19.4%) |
| Sep 2016 | - | $63.80M(+101.3%) | -$333.30M(-10.8%) |
| Jun 2016 | - | $31.70M(-108.6%) | -$373.50M(-18.1%) |
| Mar 2016 | - | -$369.10M(+518.3%) | -$455.80M(+187.4%) |
| Dec 2015 | -$158.60M(+3.7%) | -$59.70M(-353.0%) | -$158.60M(+199.2%) |
| Sep 2015 | - | $23.60M(-146.6%) | -$53.00M(+90.0%) |
| Jun 2015 | - | -$50.60M(-29.6%) | -$27.90M(-65.6%) |
| Mar 2015 | - | -$71.90M(-256.6%) | -$81.10M(-47.0%) |
| Dec 2014 | -$153.00M(-538.4%) | $45.90M(-5.7%) | -$153.00M(+29.2%) |
| Sep 2014 | - | $48.70M(-146.9%) | -$118.40M(+20.2%) |
| Jun 2014 | - | -$103.80M(-27.8%) | -$98.50M(+17.3%) |
| Mar 2014 | - | -$143.80M(-278.6%) | -$84.00M(-340.7%) |
| Dec 2013 | $34.90M(-122.4%) | $80.50M(+17.3%) | $34.90M(-118.1%) |
| Sep 2013 | - | $68.60M(-176.8%) | -$192.50M(-26.4%) |
| Jun 2013 | - | -$89.30M(+258.6%) | -$261.60M(+47.5%) |
| Mar 2013 | - | -$24.90M(-83.0%) | -$177.40M(+14.0%) |
| Dec 2012 | -$155.60M | -$146.90M(>+9900.0%) | -$155.60M(+149.8%) |
| Sep 2012 | - | -$500.00K(-90.2%) | -$62.30M(-60.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2012 | - | -$5.10M(+64.5%) | -$159.00M(-19.6%) |
| Mar 2012 | - | -$3.10M(-94.2%) | -$197.80M(+46.3%) |
| Dec 2011 | -$135.20M(+30.1%) | -$53.60M(-44.9%) | -$135.20M(+25.0%) |
| Sep 2011 | - | -$97.20M(+121.4%) | -$108.20M(+60.1%) |
| Jun 2011 | - | -$43.90M(-173.8%) | -$67.60M(+77.9%) |
| Mar 2011 | - | $59.50M(-323.7%) | -$38.00M(-63.4%) |
| Dec 2010 | -$103.90M(+13.2%) | -$26.60M(-53.0%) | -$103.90M(+41.6%) |
| Sep 2010 | - | -$56.60M(+295.8%) | -$73.40M(+70.3%) |
| Jun 2010 | - | -$14.30M(+123.4%) | -$43.10M(-2.7%) |
| Mar 2010 | - | -$6.40M(-264.1%) | -$44.30M(-51.7%) |
| Dec 2009 | -$91.80M(-31.5%) | $3.90M(-114.8%) | -$91.80M(-35.0%) |
| Sep 2009 | - | -$26.30M(+69.7%) | -$141.30M(+31.1%) |
| Jun 2009 | - | -$15.50M(-71.2%) | -$107.80M(+20.6%) |
| Mar 2009 | - | -$53.90M(+18.2%) | -$89.40M(-33.3%) |
| Dec 2008 | -$134.10M(+24.1%) | -$45.60M(-733.3%) | -$134.10M(+25.6%) |
| Sep 2008 | - | $7.20M(+148.3%) | -$106.80M(-28.8%) |
| Jun 2008 | - | $2.90M(-102.9%) | -$150.10M(-21.0%) |
| Mar 2008 | - | -$98.60M(+438.8%) | -$189.90M(+75.7%) |
| Dec 2007 | -$108.10M(-44.2%) | -$18.30M(-49.3%) | -$108.10M(-11.5%) |
| Sep 2007 | - | -$36.10M(-2.2%) | -$122.10M(-16.8%) |
| Jun 2007 | - | -$36.90M(+119.6%) | -$146.80M(-11.2%) |
| Mar 2007 | - | -$16.80M(-48.0%) | -$165.40M(-14.6%) |
| Dec 2006 | -$193.60M(-767.6%) | -$32.30M(-46.9%) | -$193.60M(+82.5%) |
| Sep 2006 | - | -$60.80M(+9.5%) | -$106.10M(+33.3%) |
| Jun 2006 | - | -$55.50M(+23.3%) | -$79.60M(+339.8%) |
| Mar 2006 | - | -$45.00M(-181.5%) | -$18.10M(-162.4%) |
| Dec 2005 | $29.00M(-241.5%) | $55.20M(-260.9%) | $29.00M(-164.2%) |
| Sep 2005 | - | -$34.30M(-671.7%) | -$45.20M(-27.6%) |
| Jun 2005 | - | $6.00M(+185.7%) | -$62.40M(-30.7%) |
| Mar 2005 | - | $2.10M(-111.1%) | -$90.10M(+339.5%) |
| Dec 2004 | -$20.50M(-3.3%) | -$19.00M(-63.1%) | -$20.50M(-39.9%) |
| Sep 2004 | - | -$51.50M(+137.3%) | -$34.10M(+326.3%) |
| Jun 2004 | - | -$21.70M(-130.3%) | -$8.00M(-134.3%) |
| Mar 2004 | - | $71.70M(-319.9%) | $23.30M(-209.9%) |
| Dec 2003 | -$21.20M(-69.5%) | -$32.60M(+28.3%) | -$21.20M(-705.7%) |
| Sep 2003 | - | -$25.40M(-364.6%) | $3.50M(-40.7%) |
| Jun 2003 | - | $9.60M(-64.7%) | $5.90M(-118.6%) |
| Mar 2003 | - | $27.20M(-444.3%) | -$31.80M(-54.2%) |
| Dec 2002 | -$69.50M(-10.9%) | -$7.90M(-65.7%) | -$69.50M(-2.8%) |
| Sep 2002 | - | -$23.00M(-18.1%) | -$71.50M(-28.4%) |
| Jun 2002 | - | -$28.10M(+167.6%) | -$99.80M(+1.4%) |
| Mar 2002 | - | -$10.50M(+6.1%) | -$98.40M(+26.2%) |
| Dec 2001 | -$78.00M(+110.8%) | -$9.90M(-80.7%) | -$78.00M(-14.9%) |
| Sep 2001 | - | -$51.30M(+92.1%) | -$91.70M(+31.4%) |
| Jun 2001 | - | -$26.70M(-369.7%) | -$69.80M(+54.8%) |
| Mar 2001 | - | $9.90M(-141.9%) | -$45.10M(+21.9%) |
| Dec 2000 | -$37.00M(-70.9%) | -$23.60M(-19.7%) | -$37.00M(+176.1%) |
| Sep 2000 | - | -$29.40M(+1370.0%) | -$13.40M(-183.8%) |
| Jun 2000 | - | -$2.00M(-111.1%) | $16.00M(-11.1%) |
| Mar 2000 | - | $18.00M | $18.00M |
| Dec 1999 | -$127.00M | - | - |
FAQ
- What is Edwards Lifesciences annual cash flow from financing activities?
- What is the all time high annual CFF for Edwards Lifesciences?
- What is Edwards Lifesciences annual CFF year-on-year change?
- What is Edwards Lifesciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly CFF year-on-year change?
- What is Edwards Lifesciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Edwards Lifesciences?
- What is Edwards Lifesciences TTM CFF year-on-year change?
What is Edwards Lifesciences annual cash flow from financing activities?
The current annual CFF of EW is -$983.00M
What is the all time high annual CFF for Edwards Lifesciences?
Edwards Lifesciences all-time high annual cash flow from financing activities is $34.90M
What is Edwards Lifesciences annual CFF year-on-year change?
Over the past year, EW annual cash flow from financing activities has changed by -$272.00M (-38.26%)
What is Edwards Lifesciences quarterly cash flow from financing activities?
The current quarterly CFF of EW is -$258.00M
What is the all time high quarterly CFF for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly cash flow from financing activities is $126.80M
What is Edwards Lifesciences quarterly CFF year-on-year change?
Over the past year, EW quarterly cash flow from financing activities has changed by -$319.70M (-518.15%)
What is Edwards Lifesciences TTM cash flow from financing activities?
The current TTM CFF of EW is -$1.30B
What is the all time high TTM CFF for Edwards Lifesciences?
Edwards Lifesciences all-time high TTM cash flow from financing activities is $34.90M
What is Edwards Lifesciences TTM CFF year-on-year change?
Over the past year, EW TTM cash flow from financing activities has changed by -$860.00M (-194.26%)